1-4 of 4
Keywords: Doxorubicin
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Clin Sci (Lond) (2022) 136 (11): 841–860.
Published: 01 June 2022
... to cardiotoxicity following a high cumulative dose of doxorubicin (DOX). A mitochondrial division inhibitor-1 (Mdivi-1) and fusion promoter (M1) have been shown to be cardioprotective in a variety of cardiovascular settings, however, their anticardiotoxic efficacy against DOX therapy remains unclear. We therefore...
Clin Sci (Lond) (2011) 121 (9): 405–413.
Published: 12 July 2011
...Xavier Marechal; David Montaigne; Camille Marciniak; Philippe Marchetti; Sidi Mohamed Hassoun; Jean Claude Beauvillain; Steve Lancel; Remi Neviere We tested whether inhibition of mitochondrial membrane potential dissipation by CsA (ciclosporin A) would prevent doxorubicin-induced myocardial...
Clin Sci (Lond) (2001) 101 (6): 601–607.
Published: 26 October 2001
...Tapio NOUSIAINEN; Esko VANNINEN; Esa JANTUNEN; Jouko REMES; Eira RITANEN; Olli VUOLTEENAHO; Juha HARTIKAINEN Doxorubicin-induced cardiotoxicity was used as a model to prospectively investigate neuroendocrine changes during the development of left ventricular dysfunction. Radionuclide...
Clin Sci (Lond) (1996) 90 (5): 393–401.
Published: 01 May 1996
... blood pressure doxorubicin glomerulosclerosis lisinopril proteinuria Clinical Science (1996) 90, 393401 (Printed in Great Britain) 393 Antiproteinuric e f k t predicts renal protection by angiotensin-converting enzyme inhibition in rats with established ad r iam yci n nephrosis Frits H. WAPSTRA...